Description of the 3 Tranquillo Phase 3 Clinical Program Study Designs to Assess Ritlecitinib Treatment in Adults and Adolescents With Nonsegmental Vitiligo. J of Skin 2025, 9 (6), s714. https://doi.org/10.25251/rm8etw25.